{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/650315b3a02e020011aea566/69c0418562f6c66afe5bb61c?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"How To Reach Series A In Consumer Women's Health","description":"<p><a href=\"https://www.linkedin.com/in/valerielevans/\" rel=\"noopener noreferrer\" target=\"_blank\">Valerie Evans</a> is a principal at Five Seasons Ventures&nbsp;</p><p><br></p><p>Five Seasons Ventures is the leading pan-European Venture Capital fund investing in iconic and sustainable consumer brands.</p><p>Whilst not a women’s health specific fund Valerie is very passionate about seeing more consumer women’s health innovation reaching series A and she walks us through the main 2 problems she sees when moving from seed- series A</p><p><br></p><p><strong>What We Cover:</strong></p><p><br></p><p>The Niche Problem Most early-stage startup advice tells founders to go narrow — solve one problem, find your 1,000 true fans. But VC math demands a big TAM. We unpack how to navigate that tension and how the right answer actually shifts as you move through funding rounds.</p><p><br></p><p>The Healthtech Identity Trap Are companies hurting themselves by leading with \"healthtech\" when trying to reach everyday consumers? We explore why leaning too hard into a clinical or tech-forward identity can create distance with the very audience you're trying to reach.</p><p><br></p><p>GTM as a Consumer Company First How do you build a go-to-market strategy that puts the consumer experience front and centre, without losing sight of longer-term opportunities in medical devices or regulated health? We discuss whether the healthtech path is a form of defensibility, a marketing play, or both.</p><p><br></p><p><strong>Key Themes:</strong></p><ul><li>Niche vs. scale in early-stage startups</li><li>Consumer brand identity in health and wellness</li><li>The role of medical device / healthtech positioning as a strategic asset</li><li>How GTM strategy evolves across funding stages</li><li><br></li></ul><p>Our podcast is sponsored by:</p><p><br></p><p>Progyny Global. A company that provides best-in-class fertility, pregnancy, postpartum and menopause benefits for the modern global workforce. Progyny Global offers an inclusive platform that connects employees with top experts, clinics, and treatments around the world. To learn more visit:<a href=\"https://progynyglobal.com/#contact\" rel=\"noopener noreferrer\" target=\"_blank\"> https://progynyglobal.com/#contact</a> or to get in touch with our team directly via email (Sasha.tory@progynyglobal.com)</p><p><br></p><p><br></p>","author_name":"Leo Tyson"}